Simblante, Marck .
HRN: 27-08-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/08/2025
05/15/2025
IV
600 Mg
Q6
Abscess
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes